======= ANKRD11 ======= == Gene Information == * **Official Symbol**: ANKRD11 * **Official Name**: ankyrin repeat domain 11 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=29123|29123]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q6UB99|Q6UB99]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ANKRD11&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANKRD11|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611192|Open OMIM]] == Function Summary == * **Entrez Summary**: This locus encodes an ankryin repeat domain-containing protein. The encoded protein inhibits ligand-dependent activation of transcription. Mutations in this gene have been associated with KBG syndrome, which is characterized by macrodontia, distinctive craniofacial features, short stature, skeletal anomalies, global developmental delay, seizures and intellectual disability. Alternatively spliced transcript variants have been described. Related pseudogenes exist on chromosomes 2 and X. [provided by RefSeq, Jan 2012]. * **UniProt Summary**: Chromatin regulator which modulates histone acetylation and gene expression in neural precursor cells (By similarity). May recruit histone deacetylases (HDACs) to the p160 coactivators/nuclear receptor complex to inhibit ligand-dependent transactivation (PubMed:15184363). Has a role in proliferation and development of cortical neural precursors (PubMed:25556659). May also regulate bone homeostasis (By similarity). {ECO:0000250|UniProtKB:E9Q4F7, ECO:0000269|PubMed:15184363, ECO:0000269|PubMed:25556659}. |Ank| |Ank 2| |face morphogenesis| |head morphogenesis| |body morphogenesis| |face development| |multicellular organism growth| |odontogenesis of dentin-containing tooth| |odontogenesis| |tissue homeostasis| |bone development| |skeletal system morphogenesis| |multicellular organismal homeostasis| |anatomical structure homeostasis| |in utero embryonic development| |developmental growth| |growth| |skeletal system development| |chordate embryonic development| |embryo development ending in birth or egg hatching| |head development| |animal organ morphogenesis| |embryo development| |homeostatic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp290|LLY-283 2.6μM R06 exp290]]|-2.37| |[[:results:exp73|LJH685 5μM R02 exp73]]|-2.04| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|-2.01| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-1.83| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|-1.79| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-1.77| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|-1.76| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|-1.76| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|1.7| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|1.85| |[[:results:exp484|GSK-J5 1.5μM R08 exp484]]|1.9| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|1.91| |[[:results:exp530|Thioridazine 5μM R08 exp530]]|1.95| |[[:results:exp349|Cytochalasin-B 5μM R07 exp349]]|1.99| |[[:results:exp429|Rapamycin 0.001μM R08 exp429]]|2.27| ^Gene^Correlation^ |[[:human genes:k:kmt2e|KMT2E]]|0.495| Global Fraction of Cell Lines Where Essential: 10/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|4/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|2/75| |lymphocyte|1/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2544 * **Expression level (log2 read counts)**: 8.57 {{:chemogenomics:nalm6 dist.png?nolink |}}